Get the Daily Brief
Latest Biotech News
FDA Pilot Program Expedites Review of Generic Drugs Using Domestic Ingredients
The U.S. Food and Drug Administration (FDA) initiated a pilot program to accelerate regulatory review for generic drugs manufactured and tested entirely with domestically sourced active...
Regencell’s Stock Swells on Speculative Surge, Despite No FDA Approvals
Regencell Bioscience Holdings, a Hong Kong-based biotech focused on Traditional Chinese Medicine (TCM) treatments for neurocognitive disorders, experienced an extraordinary stock rally in 2025,...
FDA Greenlights UCLA’s AD-NP1 Heart Regeneration Drug: Clinical Trials Begin
The FDA has approved the novel therapeutic AD-NP1 developed by UCLA cardiologists, targeting a protein that inhibits tissue regeneration in vital organs such as the heart and kidneys. This...
Skye Bioscience’s Nimacimab Falters in Phase 2 Obesity Trial – Combination Therapy Shows Promise
Skye Bioscience’s obesity drug nimacimab, a peripherally restricted CB1 receptor inhibitor antibody, failed to meet the primary endpoint in a 26-week Phase 2a trial as monotherapy, resulting in a...
Arbor Biotechnologies and Chiesi Seal Over $2 Billion Deal for Gene Editing Rare Disease Therapies
Arbor Biotechnologies has entered a landmark partnership with Chiesi Group, granting exclusive global rights and up to $2.1 billion in payments for the development and commercialization of ABO-101...
Asimov Launches Stable AAV Producer Cell Lines to Boost Gene Therapy Manufacturing
Asimov has unveiled its AAV Edge Stable Producer system, a synthetic biology breakthrough that stably integrates viral genes into HEK293 cells to produce high-titer AAV vectors without transient...
AstraZeneca and Daiichi Sankyo’s Datroway Extends Survival in Difficult-to-Treat Triple-Negative Breast Cancer
Datroway, AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate, showed prolonged survival in patients with advanced triple-negative breast cancer who are ineligible for immunotherapy. This...
Breakthroughs in AI for Cancer Prognosis and Toxicity Prediction Enhance Precision Oncology
Advanced artificial intelligence models are making significant strides in oncology by predicting patient outcomes and treatment toxicities across cancer types. Using transformer models with...
Nobel Prize Honors Discovery of Regulatory T Cells Transforming Autoimmune Disease Understanding
The 2025 Nobel Prize in Physiology or Medicine was jointly awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal work elucidating regulatory T cells (T-regs), a class of...
Geisinger MyCode’s ‘Genomic-First’ Approach Identifies Undiagnosed Rare Disease Variants
Researchers at Geisinger applied a genomic-first strategy analyzing exome sequences from over 218,000 participants, uncovering pathogenic variants in 2.5% of individuals across 490 rare disease...
Precision Neuro's Minimally Invasive Brain-Computer Interface Demonstrates Early Feasibility
The brain-computer interface system developed by Precision Neuroscience Corp. shows promising capability to capture high-resolution neural signals and stimulate brain regions without damaging the...
CareDx Secures IVDR Certification for Advanced Transplant Compatibility Testing Platforms
CareDx announced successful IVDR certification in the European Union for its AlloSeq Tx and QType platforms, which leverage next-generation sequencing and RT-PCR technologies for enhanced human...
Nobel Prize Awarded for Peripheral Immune Tolerance Discoveries
The 2025 Nobel Prize in Physiology or Medicine has been jointly awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal discoveries on regulatory T cells (Tregs) and their...
Skye Bioscience Obesity Drug Fails Mid-Stage Trial, Shares Plummet
Skye Bioscience’s cannabinoid receptor 1 (CB1) antagonist, nimacimab, failed to achieve significant weight loss compared to placebo in a mid-stage clinical trial involving overweight and obese...
FDA Pilots Program to Accelerate Domestic Generic Drug Manufacturing
The U.S. Food and Drug Administration (FDA) has launched a pilot initiative to expedite the approval process for generic drugs manufactured domestically with active pharmaceutical ingredients...
AstraZeneca and Algen Biotechnologies Ink $555M AI-Driven Drug Discovery Deal
AstraZeneca and San Francisco-based Algen Biotechnologies have entered a strategic collaboration worth up to $555 million, leveraging Algen’s AI-powered AlgenBrain platform that integrates...
Aerska Emerges with $21M to Develop RNAi Neurological Therapeutics
Dublin-based biotech Aerska has publicly emerged from stealth mode following a $21 million financing round aimed at advancing its platform for RNA interference (RNAi) therapeutics targeting...
Illinois Health Biotechnology Booms with Supportive Ecosystem and Policy
Illinois has solidified its position as a fast-growing biotech hub, with over 93,000 life sciences workers earning an average salary of $153,000, growing at 7.5% annually since 2019—20 times...
Cancer Drug Datroway Shows Phase 3 Promise in Triple-Negative Breast Cancer
AstraZeneca and Daiichi Sankyo have reported positive Phase 3 clinical trial results for Datroway (their novel antibody-drug conjugate) in treatment of hard-to-treat triple-negative breast cancer...
Regencell Bioscience’s Stock Surges and Crashes Amid Speculative Frenzy
Regencell Bioscience Holdings, a Hong Kong-based biotech focusing on Traditional Chinese Medicine (TCM) herbal formulas for neurocognitive disorders, witnessed unprecedented stock volatility in...